BioNTech (BNTX) Earnings Analysis

BioNTech (BNTX) next reports earnings on 2026-08-03, consensus EPS -2.39866 USD. Last quarter (2026-03-10) it missed with EPS -0.38 USD vs -0.22 USD est (-72.7%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -15.68.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BNTX next report earnings?

Next earnings date2026-08-03
Consensus EPS estimate-2.39866 USD
Revenue estimate0.18B

BNTX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-10-0.38 USD-0.22 USD-72.7%Miss
2025-11-03-0.14 USD-1.11715 USD+87.5%Beat
2025-08-04-1.82 USD-2.68927 USD+32.3%Beat
2025-05-05-1.82 USD-2.47778 USD+26.5%Beat
2025-03-101.15 USD0.4624 USD+148.7%Beat
2024-11-040.89 USD-1.74151 USD+151.1%Beat
2024-08-05-3.62 USD-2.19157 USD-65.2%Miss

Beat rate: 5/7 (71%) over reported quarters with consensus data.

BNTX valuation and analyst view

Trailing P/E-15.68
Trailing EPS-4.93298 USD
Price / book1.07
Dividend yield0.00%
Market cap23.24B
Analyst consensusBuy (21 buy / 3 hold / 0 sell)
Avg price target127 USD

Related research pages

Frequently asked questions

When is BioNTech (BNTX)'s next earnings date?

BioNTech is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -2.39866 USD and revenue estimate of 0.18B.

Did BNTX beat earnings last quarter?

In its 2026-03-10 report, BNTX posted EPS of -0.38 USD versus a -0.22 USD estimate — a miss of 72.7%.

What is BNTX's earnings track record?

Over the last 7 reported quarters with consensus data, BNTX beat estimates 5 times (71%).

What is BNTX's current P/E ratio and EPS?

BNTX trades at a trailing P/E of -15.68 on trailing EPS of -4.932979023049046 USD.

What do analysts rate BNTX?

Analyst consensus is "Buy" across 24 ratings (0 strong buy, 21 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 127 USD.